In vivo single-cell transcriptomics reveal Klebsiella pneumoniae skews lung macrophages to promote infection

Amy Dumigan1, Oisin Cappa1, Brenda Morris1

  • 1Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.

EMBO Molecular Medicine
|November 7, 2022
PubMed

Insights

Klebsiella pneumoniae manipulates lung macrophages to create a unique M(Kp) state, promoting bacterial survival. Targeting the STAT6 pathway offers a novel strategy to enhance host defenses against this antibiotic-resistant pathogen.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Antibiotic-resistant bacteria pose a significant threat, yet their strategies to evade host defenses remain unclear.
  • Understanding host-pathogen interactions is crucial for developing new therapeutic approaches.

Purpose of the Study:

  • To elucidate the novel host-pathogen interactions between Klebsiella pneumoniae and lung macrophages.
  • To identify the mechanisms by which Klebsiella pneumoniae manipulates macrophage polarization.

Main Methods:

  • Single-cell transcriptomics and trajectory analysis of infected lung macrophages.
  • Investigation of the Toll-like receptor (TLR)-type I IFN-IL10-STAT6 signaling axis.
  • Assessment of the role of glycolysis and capsule polysaccharide in macrophage polarization.

Main Results:

  • Klebsiella pneumoniae skews interstitial macrophages (IMs) towards a unique M2-type polarization termed M(Kp).
  • The bacterium hijacks a TLR-type I IFN-IL10-STAT6 pathway to induce M(Kp) polarization.
  • STAT6 deficiency and glycolysis inhibition enhance Klebsiella clearance in vivo, while capsule polysaccharide governs M(Kp).

Conclusions:

  • Klebsiella pneumoniae employs a novel strategy of inducing M(Kp) macrophage polarization to overcome host defenses.
  • Targeting the STAT6 pathway presents a promising therapeutic strategy to bolster host immunity against Klebsiella infections.